[go: up one dir, main page]

GB9200949D0 - Diagnostic peptides - Google Patents

Diagnostic peptides

Info

Publication number
GB9200949D0
GB9200949D0 GB929200949A GB9200949A GB9200949D0 GB 9200949 D0 GB9200949 D0 GB 9200949D0 GB 929200949 A GB929200949 A GB 929200949A GB 9200949 A GB9200949 A GB 9200949A GB 9200949 D0 GB9200949 D0 GB 9200949D0
Authority
GB
United Kingdom
Prior art keywords
diagnostic peptides
peptides
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929200949A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB929200949A priority Critical patent/GB9200949D0/en
Publication of GB9200949D0 publication Critical patent/GB9200949D0/en
Priority to PCT/GB1993/000087 priority patent/WO1993014118A1/en
Priority to AU33586/93A priority patent/AU3358693A/en
Pending legal-status Critical Current

Links

GB929200949A 1992-01-17 1992-01-17 Diagnostic peptides Pending GB9200949D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB929200949A GB9200949D0 (en) 1992-01-17 1992-01-17 Diagnostic peptides
PCT/GB1993/000087 WO1993014118A1 (en) 1992-01-17 1993-01-15 Peptide fragments of hsp71 of m. tuberculosis and their use in diagnosis of tuberculosis
AU33586/93A AU3358693A (en) 1992-01-17 1993-01-15 Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200949A GB9200949D0 (en) 1992-01-17 1992-01-17 Diagnostic peptides

Publications (1)

Publication Number Publication Date
GB9200949D0 true GB9200949D0 (en) 1992-03-11

Family

ID=10708733

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929200949A Pending GB9200949D0 (en) 1992-01-17 1992-01-17 Diagnostic peptides

Country Status (3)

Country Link
AU (1) AU3358693A (en)
GB (1) GB9200949D0 (en)
WO (1) WO1993014118A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1097795A (en) 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
EP2295065B1 (en) 1998-02-20 2013-10-09 The University of Miami Modified heat shock protein-antigenic peptide complex
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
EP1252517A4 (en) * 2000-01-21 2004-10-20 Wistar Inst BIOCIDAL MOLECULES, MACROMOLECULAR TARGETS, AND METHODS OF PRODUCTION AND USE
EP1286693A4 (en) 2000-06-02 2005-07-13 Univ Connecticut Health Ct COMPLEXES OF ALPHA-2-MACROGLOBULIN AND ANTIGENIC MOLECULES FOR IMMUNOTHERAPY
CA2457008A1 (en) 2001-08-20 2003-02-27 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
US8728170B1 (en) 2006-12-28 2014-05-20 Boston Scientific Scimed, Inc. Bioerodible nano-fibrous and nano-porous conductive composites
AU2009223838B2 (en) 2008-03-03 2012-07-26 The University Of Miami Allogeneic cancer cell-based immunotherapy
EP2274001A4 (en) 2008-03-20 2012-08-01 Univ Miami GP96 THERMAL IMPACT PROTEIN VACCINATION AND METHODS OF USE
JP6744318B2 (en) 2015-02-06 2020-08-26 ヒート バイオロジクス,インコーポレイテッド Vector co-expressing vaccine and costimulatory molecule
CA3040123A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
WO2018187260A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1548388A (en) * 1987-02-02 1988-08-24 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes and encoding protein antigens
AU6807390A (en) * 1989-12-22 1991-06-27 Astra Aktiebolag New methods of diagnosis of tuberculosis

Also Published As

Publication number Publication date
WO1993014118A1 (en) 1993-07-22
AU3358693A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
KR0163647B1 (en) Diagnostic patch
GB9200949D0 (en) Diagnostic peptides
ZA928511B (en) Peptides
AP9400605A0 (en) New peptides
PL318017A1 (en) Peptides
GB9111291D0 (en) Diagnostic peptides
GB9325519D0 (en) Peptides
IL108353A0 (en) Novel peptides
GB9016810D0 (en) Peptides
GB9425380D0 (en) Peptides
PL299367A1 (en) Linear peptides
ZA931299B (en) Novel peptides
GB9211677D0 (en) Peptide compounds
GB9425381D0 (en) Peptides
LV10287B (en) Peptide compounds
ZA935126B (en) Peptides
GB9210074D0 (en) Peptides
GB9323794D0 (en) Diagnostic
GB9226074D0 (en) Peptide
GB9222167D0 (en) Diagnostic methods
ZA944337B (en) Peptides
ZA94211B (en) Peptides
AU292P (en) WARRIGAL Glycine max
GB9028140D0 (en) Peptides